Table 2 Treatment characteristics.
From: Accurate surgical navigation with real-time tumor tracking in cancer surgery
Characteristics | Feasibility phase, n = 15 | Test phase, n = 16 |
|---|---|---|
Fiducial markers | 8 (53.3) | 16 (100.0) |
Type of surgery | ||
Open APR | 4 (26.7) | 4 (25.0) |
Lap. APR | 3 (20.0) | 4 (25.0) |
Open LAR | 5 (33.3) | 3 (18.8) |
Lap. LAR | 3 (20.0) | 3 (18.8) |
No navigated surgery performed | 0 (0) | 2 (12.5) |
Surgery with navigation | 11 (73.3) | 14 (87.5) |
Technical navigation errors | ||
Tumor sensor-related | 4 (26.7) | 0 (0) |
Registration-related | 0 (0) | 1 (6.3) |
Study-related severe adverse eventsa | 0 (0) | 1 (6.3) |
Intraoperative complicationsb | ||
Navigation related | 0 (0) | 0 (0) |
Non-navigation related | 0 (0) | 1 (6.3) |
Median extra time needed (min–max) | 31 (21–46) | 21 (15–30) |
